Hepatitis B: Liver fibrosis and hepatocellular carcinoma

Gastroenterologie Clinique et Biologique

Volumn 33, Issue 10-11, 2009, Pages 911-915

  Lok, A S F ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ALGORITHM; CANCER RISK; CANCER STAGING; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; ELASTOGRAPHY; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; LABORATORY TEST; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER RESECTION; NON INVASIVE MEASUREMENT; NONALCOHOLIC FATTY LIVER; NONHUMAN; PREDICTION; PROMOTER REGION; PROSPECTIVE STUDY; REFERENCE VALUE; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; SHORT SURVEY; VIRUS MUTATION; VIRUS REPLICATION;

BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; GENOTYPE; HEPATITIS B ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; RISK FACTORS;

EID: 70350621896     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2009.06.001     Document Type: Short Survey

References (31)

1. Fattovich G., Bortolotti F., and Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 48 (2008) 335-352
2. Bralet M.P., Regimbeau J.M., Pineau P., Dubois S., Loas G., Degos F., et al. Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology 32 (2000) 200-204
3. Lam C., Chan A.O., Ho P., Ng I.O., Lo C.M., Liu C.L., et al. Different Presentation of Hepatitis B-related Hepatocellular Carcinoma in a Cohort of 1863 Young and Old Patients - Implications for Screening. Pharmacol Ther 19 (2004) 771-777
4. Paradis V., Zalinski S., Chelbi E., Guedj N., Degos F., Vilgrain V., et al. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology 49 (2009) 851-859
5. Lok A.S., Seeff L.B., Morgan T.R., di Bisceglie A.M., Sterling R.K., Curto T.M., et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology 136 (2009) 138-148
6. Beasley R.P. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61 (1988) 1942-1956
7. Chen C.J., Yang H.I., Su J., Jen C.L., You S.L., Lu S.N., et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295 (2006) 65-73
8. Rockey D.C., Caldwell S.H., Goodman Z.D., Nelson R.C., and Smith A.D. Liver biopsy. Hepatology 49 (2009) 1017-1044
9. Afdhal N.H., and Curry M. Technology evaluation: a critical step in the clinical utilization of novel diagnostic tests for liver fibrosis. J Hepatol 46 (2007) 543-545
10. de Lédinghen V, Vergniol J. Transient elastography. Gastroenterol Clin Biol 2008, 32 (suppl. 1):58-67.
11. Poynard T., Ngo Y., Marcellin P., Hadziyannis S., Ratziu V., and Benhamou Y. Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest-ActiTest) in patients infected by hepatitis B virus. J Viral Hepat 16 (2009) 203-213
12. Imbert-Bismut F., Ratziu V., Pieroni L., Charlotte F., Benhamou Y., and Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 357 (2001) 1069-1075
13. Wai C.T., Greenson J.K., Fontana R.J., Kalbfleisch J.D., Marrero J.A., Conjeevaram H.S., et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38 (2003) 518-526
14. Zhang Y.X., Wu W.J., Zhang Y.Z., Feng Y.L., Zhou X.X., and Pan Q. Noninvasive assessment of liver fibrosis with combined serum aminotransferase/platelet ratio index and hyaluronic acid in patients with chronic hepatitis B. World J Gastroenterol 14 (2008) 7117-7121
15. Forns X., Ampurdanes S., Llovet J.M., Aponte J., Quinto L., Martinez-Bauer E., et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 36 (2002) 986-992
16. Islam S., Antonsson L., Westin J., and Lagging M. Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers. Scand J Gastroenterol 40 (2005) 867-872
17. Hui A.Y., Chan H.L., Wong V.W., Liew C.T., Chim A.M., Chan F.K., et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol 100 (2005) 616-623
18. Sebastiani G., Vario A., Guido M., and Alberti A. Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 13 (2007) 525-531
19. Chan H.L., Wong G.L., Choi P.C., Chan A.W., Chim A.M., Yiu K.K., et al. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat 16 (2009) 36-44
20. Wong G.L., Wong V.W., Choi P.C., Chan A.W., Chim A.M., Yiu K.K., et al. Evaluation of alanine transaminase and hepatitis B virus DNA to predict liver cirrhosis in hepatitis B e antigen-negative chronic hepatitis B using transient elastography. Am J Gastroenterol 103 (2008) 3071-3081
21. Oliveri F., Coco B., Ciccorossi P., Colombatto P., Romagnoli V., Cherubini B., et al. Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases. World J Gastroenterol 14 (2008) 6154-6162
22. Yuen M.F., Tanaka Y., Fong D.Y., Fung J., Wong D.K., Yuen J.C., et al. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatol 50 (2009) 80-88
23. Yang H.I., Lu S.N., Liaw Y.F., You S.L., Sun C.A., Wang L.Y., et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 347 (2002) 168-174
24. Yu M.W., Yeh S.H., Chen P.J., Liaw Y.F., Lin C.L., Liu C.J., et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst 97 (2005) 265-272
25. Chen G., Lin W.Y., Shen F.M., Iloeje U.H., London W.T., and Evans A.A. Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study. Am J Gastroenterol 101 (2006) 1797-1803
26. Chen C.J., Yang H.I., Su J., Jen C.L., You S.L., Chen C.F., et al. Impact of chronically elevated HBV DNA viral load on risk of HCC occurrence: an update from the R. E. V. E. A. L. -HBV Study (abstract). Hepatology 46 Suppl. 1 (2007) 646A
27. Yang H.I., Yeh S.H., Chen P.J., Iloeje U.H., Jen C.L., Su J., et al. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst 100 (2008) 1134-1143
28. Chu C.J., Hussain M., Lok A.S., and Hepatitis. B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 122 (2002) 1756-1762
29. Chu C.J., Keeffe E.B., Han S.H., Perrillo R.P., Min A.D., Soldevila-Pico C., et al. Prevalence of HBV precore/core promoter variants in the United States. Hepatology 38 (2003) 619-628
30. Kew M.C., Kramvis A., Yu M.C., Arakawa K., and Hodkinson J. Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu-speaking sub-saharan Africans. J Med Virol 75 (2005) 513-521
31. Livingston S.E., Simonetti J.P., McMahon B.J., Bulkow L.R., Hurlburt K.J., Homan C.E., et al. Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. J Infect Dis 195 (2007) 5-11